Form 4: Alignment Healthcare Executive Christopher J. Joyce Sells 25,000 Shares

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold 25,000 shares of common stock on May 1, 2025, at a weighted-average price of $16.8731 per share.

Summary

• On May 1, 2025, Christopher J. Joyce, the Chief Legal and Administrative Officer of Alignment Healthcare, Inc. (ALHC), sold 25,000 shares of the company's common stock.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 27, 2024.
• The shares were sold at a weighted-average price of $16.8731, with individual prices ranging from $16.59 to $17.37.
• Following the transaction, Joyce directly owns 390,022 shares of Alignment Healthcare common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to an executive stock sale. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. They can be driven by a variety of factors, including personal financial planning and diversification. The use of Rule 10b5-1 plans allows insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some investors, but the existence of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Keywords

Alignment Healthcare, ALHC, Christopher J. Joyce, Form 4, Executive Stock Sale, Rule 10b5-1, Insider Trading